We’re delighted to announce a collaboration with @pfizer to accelerate their drug discovery efforts.
Pfizer will deploy our latest frontier AI model Chai-3 and a custom model leveraging Pfizer's proprietary data and tailored to their workflows.
Chai-3 shows step-change improvements in AI-driven antibody design, doubling the success rate of its predecessor model and producing antibodies that meet required therapeutic standards.
Our goal is a world where new medicines are not found through trial and error, but designed with the precision, speed and scale of modern engineering.
We are scaling fast and hiring for multiple roles across product, engineering, business, and science. If you are a motivated self-starter, please reach out via chaidiscovery.com/careers
2026 #ForbesAI50
Artificial intelligence has become part of our lives, increasingly core to how we work, search for information and express ideas. In the last year, the startups spearheading this paradigm shift have raised gobs of money from venture firms to build applications
There are only a few other areas where AI has the potential to change lives more than the discovery and development of new medicines to improve lives for patients.
We thank @jackdent and @BenjamineYLiu for this discussion about how America needs to continue to lead in biopharma R&D and harness AI to accelerate treatments and cures.
Thank you @LucasRopek1 for this feature in @TechCrunch highlighting our journey at @chaidiscovery.
Grateful to our partners @generalcatalyst and @EliLillyandCo for adding your perspectives on how Chai is helping to unlock medicines that have historically been difficult to drug.
Seeing a leading pharma organization move quickly to adopt these technologies reinforces our belief that many future drugs will be discovered with AI.
Grateful to the teams on both sides who made this possible. Excited to see the medicines that get created from here.
As part of this work, Chai and Lilly are building a custom foundation model, trained on Lilly’s proprietary data and tailored to their internal discovery efforts.
We’re thrilled to announce our collaboration with @EliLillyandCo.
We’ll be deploying Chai’s AI models to power biologics discovery across a broad set of drug programs at Lilly.
This is a major step forward in pharma’s adoption of AI-native R&D.
The folks @chaidiscovery have been producing potential drug designs at an incredible clip. We get into the latest (and hopefully more real) era of AI-aided drug discovery on this week's pod corememory.com/p/is-the-era-o…
.@chaidiscovery raised a Series B just three months after their Series A, and we co-led it.
GC's Elena Viboch recently joined @Bloomberg's @CarolineHydeTV alongside Chai Discovery co-founder @joshim5 to discuss our life sciences investment strategy and the breakthrough technology behind Chai Discovery.
We believe 2026 will be the year of deployment for AI in pharma. Chai Discovery’s latest model, Chai-2, has achieved an 85% success rate in computationally designing molecules that meet drug-like properties. In our view, pharmaceutical companies that adopt this technology will leapfrog those who do not.
We partner with companies like Chai Discovery to turn known biology and impossible chemistry into lifesaving treatments.
Why we invested → generalcatalyst.com/stories/our-in…
More on our life sciences thesis → generalcatalyst.com/stories/the-fu…
Chai Discovery — a startup working on AI engineering for molecules — has raised $130 million from investors including Oak HC/FT, General Catalyst, Thrive Capital, Menlo Ventures and OpenAI bloomberg.com/news/articles/…
We are actively growing our team of interdisciplinary engineers, researchers, and scientists. If you are excited by our work, we would love to hear from you: chaidiscovery.com/careers
46 Followers 113 FollowingGhostwriting for B2B founders | I turn 1hr of talk into 30 days of authority | Scaling $10k+ months through intent | DM to Build.
143 Followers 1K FollowingBiotech nerd. Watches enthusiast. Pharmacist by day, learning about bulls and bears (trading) by night. Enjoying beautiful things in life🇨🇦
433 Followers 2K FollowingPostdoc at the Broad Institute of MIT and Harvard @broadinstitute - single cell genomics, AI agents, causal paths and philosophy.
4K Followers 3K FollowingWeb3 Dev📈, Marketer & Creator building @youthspire for Web3 education x Fiverr marketing with @breakmart_ founder of @gwaliordao Crafting bold product stories
102 Followers 4K FollowingFounder of Ten Sixty AI, no.1 AI video & ad content platform for real estate
Ex-Founder of Australia's first Bitcoin Venture Fund (Anti Hero Capital)
156 Followers 1K FollowingMédico Nutrólogo, Coordenador e Professor da pós-graduação de Nutrologia do HI Albert Einstein, Médico do Esporte pela SBMEE. Colunista de Saúde UOL
26 Followers 202 FollowingLife sciences paid media strategist focused on AI workflows, scientific storytelling, and GTM strategy for biotech, diagnostics, and drug discovery. 🧬🤖